Background: Immunomodulators and biological agents, used to treat inflammatory bowel disease [IBD], are associated with an increased risk of infection, including vaccine-preventable infections. We assessed patient attitudes towards vaccination, knowledge of vaccine recommendations, and uptake of recommended vaccines. Methods: Patients attending IBD clinics completed a self-administered, structured, paper-based questionnaire. We collected demographic data, medical and immunisation history, self-reported patient uptake, knowledge, and perceptions of childhood and adult vaccinations. Results: The prevalence of treatment with biologicals, steroids, thiopurines, and methotrexate among the 300 respondents were 37.3%, 16.0%, 16.0%, and 5.7%, respe...
Abstract: The treatment of Crohn’s disease and ulcerative colitis frequently includes potent immunom...
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has complicate...
International audienceBackground: Despite specific immunization guidelines for immunocompromised pat...
Immunosuppressive agents used to treat inflammatory bowel disease (IBD) can increase the risk for in...
BACKGROUND: Despite the existence of international guidelines, vaccination in patients with inflamm...
BackgroundTo understand the awareness of COVID-19 vaccine, the willingness to vaccinate and the infl...
Background: Vaccination against COVID-19 is a major public health challenge, including the community...
peer-reviewedBackground: Poor immune responses are frequently observed in patients with inflammatory...
The COVID-19 pandemic, caused by SARS-CoV-2, has been the most significant global health crisis of t...
International audienceBACKGROUND: Children with inflammatory bowel disease are at risk of vaccine-pr...
This article has an accompanying continuing medical education activity on page e130 (https://www.sci...
Background: Vaccination has been effective in preventing COVID-19 infections and related mortality. ...
BACKGROUND: Infection with influenza A (H1N1)v (swine flu) has caused widespread anxiety, among pati...
Treatment of inflammatory bowel disease (IBD) frequently requires administration of immunosuppressiv...
Abstract: The treatment of Crohn’s disease and ulcerative colitis frequently includes potent immunom...
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has complicate...
International audienceBackground: Despite specific immunization guidelines for immunocompromised pat...
Immunosuppressive agents used to treat inflammatory bowel disease (IBD) can increase the risk for in...
BACKGROUND: Despite the existence of international guidelines, vaccination in patients with inflamm...
BackgroundTo understand the awareness of COVID-19 vaccine, the willingness to vaccinate and the infl...
Background: Vaccination against COVID-19 is a major public health challenge, including the community...
peer-reviewedBackground: Poor immune responses are frequently observed in patients with inflammatory...
The COVID-19 pandemic, caused by SARS-CoV-2, has been the most significant global health crisis of t...
International audienceBACKGROUND: Children with inflammatory bowel disease are at risk of vaccine-pr...
This article has an accompanying continuing medical education activity on page e130 (https://www.sci...
Background: Vaccination has been effective in preventing COVID-19 infections and related mortality. ...
BACKGROUND: Infection with influenza A (H1N1)v (swine flu) has caused widespread anxiety, among pati...
Treatment of inflammatory bowel disease (IBD) frequently requires administration of immunosuppressiv...
Abstract: The treatment of Crohn’s disease and ulcerative colitis frequently includes potent immunom...
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has complicate...
International audienceBackground: Despite specific immunization guidelines for immunocompromised pat...